文献速递腹部MR

微血管侵犯阴性肝细胞癌:Gd-EOB-DTPA MRI定性与定量分析的预后价值

Microvascular invasion-negative hepatocellular carcinoma: Prognostic value of qualitative and quantitative Gd-EOB-DTPA MRI analysis.
PubMed 文献 · Eur J Radiol · 2023-10-06

该回顾性研究纳入2015年1月至2019年12月术前接受Gd-EOB-DTPA MRI的微血管侵犯阴性肝细胞癌患者122例,按7:3随机分为训练组与验证组,基于定性与定量MRI特征及临床参数构建预后列线图,中位随访58.86个月期间38例(31.15%)复发,模型C指数训练组0.732、验证组0.692。

要点

  • 较低的相对强化率(RER)是微血管侵犯阴性肝细胞癌术后复发的独立危险因素,RER≤1.197者复发率显著高于RER>1.197者(p=0.004)。
  • 肝胆期低信号不伴动脉期高强化、LI-RADS类别、轻-中度T2高信号及较高的天冬氨酸氨基转移酶水平亦为预后危险因素。
  • 整合定性与定量影像参数及临床参数的列线图可较好地预测微血管侵犯阴性肝细胞癌患者的预后,训练组C指数0.732、验证组0.692。

核心结论

  • 整合定性与定量影像参数及临床参数的模型可较好地预测微血管侵犯阴性肝细胞癌患者的预后。

研究设计与样本

  • 回顾性研究,连续纳入2015年1月至2019年12月术前接受Gd-EOB-DTPA MRI的微血管侵犯阴性肝细胞癌患者122例,按7:3随机分为训练组与验证组;终点为无复发生存;采用Kaplan-Meier法及log-rank检验比较组间结局。

关键影像表现/征象

  • 较低的相对强化率(RER)为预后危险因素,RER最适截断值为1.197。
  • 肝胆期低信号不伴动脉期高强化为预后危险因素。
  • 轻-中度T2高信号为预后危险因素。
  • 较高的天冬氨酸氨基转移酶水平为预后危险因素。

诊断标准与关键数值

  • RER≤1.197者术后复发率显著高于RER>1.197者(p=0.004)。
  • 预后模型C指数训练组为0.732,验证组为0.692。
  • 多因素分析纳入的危险因素包括较低RER、肝胆期低信号不伴动脉期高强化、LI-RADS类别、轻-中度T2高信号及较高天冬氨酸氨基转移酶水平。

临床应用与阅片要点

  • 作者认为,整合定性与定量影像参数及临床参数的模型可较好地预测微血管侵犯阴性肝细胞癌患者的预后。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The purpose of this study was to establish a model for predicting the prognosis of patients with microvascular invasion (MVI)-negative hepatocellular carcinoma (HCC) based on qualitative and quantitative analyses of Gd-EOB-DTPA magnetic resonance imaging (MRI).

MATERIALS AND METHODS: Consecutive patients with MVI-negative HCC who underwent preoperative Gd-EOB-DTPA MRI between January 2015 and December 2019 were retrospectively enrolled.In total, 122 patients were randomly assigned to the training and validation groups at a ratio of 7:3. Univariate and multivariate logistic regression analyses were performed to identify significant clinical parameters and MRI features, including quantitative and qualitative parameters associated with prognosis, which were incorporated into a predictive nomogram. The end-point of this study was recurrence-free survival. Outcomes were compared between groups using the Kaplan-Meier method with the log-rank test.

RESULTS: During a median follow-up period of 58.86 months, 38 patients (31.15 %) experienced recurrence. Multivariate analysis revealed that lower relative enhancement ratio (RER), hepatobiliary phase hypointensity without arterial phase hyperenhancement, Liver Imaging Reporting and Data System category, mild-moderate T2 hyperintensity, and higher aspartate aminotransferase levels were risk factors associated with prognosis and then incorporated into the prognostic model. C-indices for training and validation groups were 0.732 and 0.692, respectively. The most appropriate cut-off value for RER was 1.197. Patients with RER ≤ 1.197 had significantly higher postoperative recurrence rates than those with RER > 1.197 (p = 0.004).

CONCLUSION: The model integrating qualitative and quantitative imaging parameters and clinical parameters satisfactorily predicted the prognosis of patients with MVI-negative HCC.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Wang L, Liang M, Feng B, et al. Microvascular invasion-negative hepatocellular carcinoma: Prognostic value of qualitative and quantitative Gd-EOB-DTPA MRI analysis. Eur J Radiol. 2023. PMID: 37832198. doi:10.1016/j.ejrad.2023.111146

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。